BSE Live
Oct 24, 13:22Prev. Close
525.60
Open Price
524.20
Bid Price (Qty.)
522.60 (110)
Offer Price (Qty.)
525.20 (9)
NSE Live
Oct 24, 13:22Prev. Close
524.15
Open Price
527.00
Bid Price (Qty.)
523.25 (136)
Offer Price (Qty.)
524.50 (1)
| Balance Sheet of Lincoln Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 20.03 | 20.03 | 20.03 | 20.03 | 20.00 | |
| Total Share Capital | 20.03 | 20.03 | 20.03 | 20.03 | 20.00 | |
| Reserves and Surplus | 651.64 | 572.81 | 482.44 | 412.85 | 344.95 | |
| Total Reserves and Surplus | 651.64 | 572.81 | 482.44 | 412.85 | 344.95 | |
| Total Shareholders Funds | 671.67 | 592.84 | 502.47 | 432.88 | 364.95 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | |
| Deferred Tax Liabilities [Net] | 13.00 | 11.46 | 7.94 | 6.45 | 3.26 | |
| Other Long Term Liabilities | 5.39 | 3.62 | 4.72 | 4.54 | 4.29 | |
| Long Term Provisions | 0.73 | 0.10 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 19.12 | 15.18 | 12.66 | 10.99 | 7.69 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 1.07 | 2.00 | 2.04 | 0.00 | |
| Trade Payables | 84.81 | 72.30 | 51.01 | 71.42 | 50.08 | |
| Other Current Liabilities | 14.78 | 15.25 | 15.08 | 14.12 | 15.80 | |
| Short Term Provisions | 6.49 | 3.52 | 4.03 | 2.66 | 0.16 | |
| Total Current Liabilities | 106.08 | 92.14 | 72.12 | 90.24 | 66.04 | |
| Total Capital And Liabilities | 796.87 | 700.15 | 587.26 | 534.11 | 438.69 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 181.53 | 179.00 | 150.23 | 131.50 | 89.50 | |
| Intangible Assets | 0.44 | 0.33 | 0.29 | 0.38 | 0.40 | |
| Capital Work-In-Progress | 4.47 | 3.48 | 6.71 | 16.05 | 1.34 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 186.44 | 182.81 | 157.24 | 147.93 | 91.24 | |
| Non-Current Investments | 0.05 | 0.05 | 0.05 | 0.05 | 25.74 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 106.00 | 65.76 | 59.31 | 26.84 | 25.09 | |
| Other Non-Current Assets | 4.63 | 4.98 | 3.65 | 6.73 | 20.89 | |
| Total Non-Current Assets | 297.12 | 253.60 | 220.26 | 181.56 | 162.97 | |
| CURRENT ASSETS | ||||||
| Current Investments | 173.72 | 138.92 | 91.33 | 96.81 | 80.66 | |
| Inventories | 78.68 | 77.17 | 70.03 | 72.74 | 40.27 | |
| Trade Receivables | 165.53 | 160.90 | 135.47 | 115.04 | 102.23 | |
| Cash And Cash Equivalents | 21.99 | 13.39 | 33.85 | 18.43 | 12.53 | |
| Short Term Loans And Advances | 35.30 | 38.44 | 23.23 | 31.78 | 18.36 | |
| OtherCurrentAssets | 24.53 | 17.73 | 13.10 | 17.76 | 21.67 | |
| Total Current Assets | 499.75 | 446.55 | 367.00 | 352.56 | 275.72 | |
| Total Assets | 796.87 | 700.15 | 587.26 | 534.11 | 438.69 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 1.12 | 2.68 | 2.47 | 7.28 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 15.56 | 0.00 | 12.25 | 5.43 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | 362.51 | -- | 269.49 | 257.37 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | 0.05 | 0.00 | 0.05 | 19.98 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | 129.18 | 91.33 | 96.81 | -- |
07.08.2025
Lincoln Pharma Standalone June 2025 Net Sales at Rs 154.07 crore, up 4.61% Y-o-Y
24.06.2025
Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y
04.03.2025
Lincoln Pharma Consolidated December 2024 Net Sales at Rs 146.55 crore, up 0.07% Y-o-Y
28.11.2024
Lincoln Pharma Consolidated September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y
07.08.2025
Lincoln Pharma Standalone June 2025 Net Sales at Rs 154.07 crore, up 4.61% Y-o-Y
24.06.2025
Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y
04.03.2025
Lincoln Pharma Consolidated December 2024 Net Sales at Rs 146.55 crore, up 0.07% Y-o-Y
28.11.2024
Lincoln Pharma Consolidated September 2024 Net Sales at Rs 161.21 crore, up 3.35% Y-o-Y